Nonalcoholic fatty liver disease
BPC-157 BPC-157 is a synthetic pentadecapeptide derived from human gastric juice, extensively studied for its regenerative properties in animal models
Research suggests that peptide MT2 may enhance glucose metabolism through MC-4R pathways, offering insights into potential mechanisms for metabolic disorder investigations
Cagrilintide was specifically engineered with molecular modifications to resist rapid breakdown in the body and bind effectively to amylin 1 and 3 (AMY1R, AMY3R) receptors in the brain, allowing for a more stable, once-weekly dosing regimen compared to the multiple daily injections required for older amylin analogues like pramlintide
It works by influencing several biological processes, including gut health and glucose metabolism
Supports anti-aging from within by protecting brain nerves, improving insulin resistance, and promoting skin glowing effects